| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5257 | 2021 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1648 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1321 | 2021 |
| Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells Q Hammer, T Rückert, EM Borst, J Dunst, A Haubner, P Durek, F Heinrich, ... Nature immunology 19 (5), 453-463, 2018 | 378 | 2018 |
| A blood atlas of COVID-19 defines hallmarks of disease severity and specificity DJ Ahern, Z Ai, M Ainsworth, C Allan, A Allcock, B Angus, MA Ansari, ... Cell 185 (5), 916-938. e58, 2022 | 156 | 2022 |
| Inflammatory monocytes and NK cells play a crucial role in DNAM-1–dependent control of cytomegalovirus infection T Lenac Rovis, P Kucan Brlic, N Kaynan, V Juranic Lisnic, I Brizic, ... Journal of Experimental Medicine 213 (9), 1835-1850, 2016 | 60 | 2016 |
| SIMON, an automated machine learning system, reveals immune signatures of influenza vaccine responses A Tomic, I Tomic, Y Rosenberg-Hasson, CL Dekker, HT Maecker, ... The Journal of Immunology 203 (3), 749-759, 2019 | 52 | 2019 |
| Cytomegalovirus m154 hinders CD48 cell-surface expression and promotes viral escape from host natural killer cell control A Zarama, N Perez-Carmona, D Farre, A Tomic, EM Borst, M Messerle, ... PLoS pathogens 10 (3), e1004000, 2014 | 40 | 2014 |
| Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1γ. T Trsan, A Busche, M Abram, FM Wensveen, NA Lemmermann, ... | 33 | 2013 |
| Divergent trajectories of antiviral memory after SARS-CoV-2 infection A Tomic, DT Skelly, A Ogbe, D O’Connor, M Pace, E Adland, F Alexander, ... Nature Communications 13 (1), 1251, 2022 | 27 | 2022 |
| Activation of innate and adaptive immunity by a recombinant human cytomegalovirus strain expressing an NKG2D ligand A Tomić, PR Varanasi, M Golemac, S Malić, P Riese, EM Borst, ... Plos pathogens 12 (12), e1006015, 2016 | 21 | 2016 |
| Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history H Hornsby, AR Nicols, S Longet, C Liu, A Tomic, A Angyal, B Kronsteiner, ... Nature communications 14 (1), 5065, 2023 | 13 | 2023 |
| SIMON: open-source knowledge discovery platform A Tomic, I Tomic, L Waldron, L Geistlinger, M Kuhn, RL Spreng, ... Patterns 2 (1), 2021 | 13 | 2021 |
| Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19 CP Kotanidis, C Xie, D Alexander, JCL Rodrigues, K Burnham, A Mentzer, ... The Lancet Digital Health 4 (10), e705-e716, 2022 | 12 | 2022 |
| The FluPRINT dataset, a multidimensional analysis of the influenza vaccine imprint on the immune system A Tomic, I Tomic, CL Dekker, HT Maecker, MM Davis Scientific data 6 (1), 214, 2019 | 11 | 2019 |
| MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination Y Kim, X Zheng, K Eschke, MZ Chaudhry, F Bertoglio, A Tomić, ... Cellular & Molecular Immunology 19 (2), 234-244, 2022 | 9 | 2022 |
| Systems immunology: revealing influenza immunological imprint A Tomic, AJ Pollard, MM Davis Viruses 13 (5), 948, 2021 | 8 | 2021 |
| Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine D O’Connor, MV Pinto, D Sheerin, A Tomic, RE Drury, S Channon‐Wells, ... Molecular systems biology 16 (11), e9888, 2020 | 7 | 2020 |
| CD4+ and CD8+ T cell and antibody correlates of protection against Delta vaccine breakthrough infection: A nested case-control study within the PITCH study I Neale, M Ali, B Kronsteiner, S Longet, P Abraham, AS Deeks, A Brown, ... medRxiv, 2023.02. 16.23285748, 2023 | 2 | 2023 |
| CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study I Neale, M Ali, B Kronsteiner, S Longet, P Abraham, AS Deeks, A Brown, ... Mbio 14 (5), e01212-23, 2023 | 1 | 2023 |
Martin MesserleMedizinische Hochschule Hannover, MHHVerified email at mh-hannover.de
